Last reviewed · How we verify

GALAXIA© Latanoprost eyedrops

University of Catanzaro · FDA-approved active Small molecule Quality 2/100

GALAXIA© Latanoprost eyedrops is a Small molecule drug developed by University of Catanzaro. It is currently FDA-approved. Also known as: GALAXIA© eyedrops (ALFA INTES Industria Terapeutica Splendore S.r.l. - Casoria (NA), Italy), authorization number:, 038622015.

At a glance

Generic nameGALAXIA© Latanoprost eyedrops
Also known asGALAXIA© eyedrops (ALFA INTES Industria Terapeutica Splendore S.r.l. - Casoria (NA), Italy), authorization number:, 038622015
SponsorUniversity of Catanzaro
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about GALAXIA© Latanoprost eyedrops

What is GALAXIA© Latanoprost eyedrops?

GALAXIA© Latanoprost eyedrops is a Small molecule drug developed by University of Catanzaro.

Who makes GALAXIA© Latanoprost eyedrops?

GALAXIA© Latanoprost eyedrops is developed and marketed by University of Catanzaro (see full University of Catanzaro pipeline at /company/university-of-catanzaro).

Is GALAXIA© Latanoprost eyedrops also known as anything else?

GALAXIA© Latanoprost eyedrops is also known as GALAXIA© eyedrops (ALFA INTES Industria Terapeutica Splendore S.r.l. - Casoria (NA), Italy), authorization number:, 038622015.

What development phase is GALAXIA© Latanoprost eyedrops in?

GALAXIA© Latanoprost eyedrops is FDA-approved (marketed).

Related